AP source: Tim Lincecum in discussions with Rangers

FILE - In this Tuesday, July 19, 2016 file photo, Los Angeles Angels starting pitcher Tim Lincecum works against the Texas Rangers in the first inning of a baseball game in Anaheim, Calif. A person with knowledge of the negotiations says two-time NL Cy Young Award winner Tim Lincecum is in discussions with the Texas Rangers on a one-year deal. The person spoke on condition of anonymity Tuesday, Feb. 27, 2018 because no contract had been reached. (AP Photo/Lenny Ignelzi, File)

Lenny Ignelzi

SURPRISE, Ariz. (AP) — Tim Lincecum arrived at the Texas Rangers' spring training camp, ready to finalize a contract and return to the major leagues for the first time in two years.

The 33-year-old right-hander took a physical Tuesday. He figures to compete for a bullpen spot.

General manager Jon Daniels said the four-time All-Star has been throwing bullpen sessions on his own since a showcase for scouts last month.

"He was in as close to game shape as you're going to be, from that standpoint," Daniels said.

Texas anticipates Lincecum will throw bullpen sessions and batting practice before getting into a spring training game.

"He's further along than I would say most guys are on report date," Daniels said.

A two-time World Series champion with San Francisco, Lincecum was 108-83 for the Giants from 2007-15. He had season-ending hip surgery in September 2015 and made a brief comeback with the Los Angeles Angels the following season, going 2-6 with a 9.16 ERA in nine starts

Texas thinks Lincecum has good hip movement, flexibility and explosiveness in his delivery.

"Between that and the transition to a bullpen role, gave us some confidence he could be a successful part of the team," Daniels said.

Lincecum has worn No. 55. Texas pitcher Matt Moore, who wears 55 now, expressed a willingness to let Lincecum have the number.


More AP baseball: https://apnews.com/tag/MLBbaseball

Copyright 2018 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.